References
- International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation. https://www.diabetesatlas.org. 2019 Accessed November 29, 2020.
- Chawla A, Chawla R, Jaggi S. Microvascular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20:546–551. doi:https://doi.org/10.4103/2230-8210.183480.
- Raman R, Gella L, Srinivasan S, Sharma T. Diabetic retinopathy: an epidemic at home and around the world. Indian J Ophthalmol. 2016;64:69–75. doi:https://doi.org/10.4103/0301-4738.178150.
- Raman R, Ganesan S, Pal SS, et al. Incidence and progression of diabetic retinopathy in Urban India: sankara Nethralaya-diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS II), Report 1. Ophthalmic Epidemiol. 2017;24:294–302. doi:https://doi.org/10.1080/09286586.2017.1290257.
- Diabetic Retinopathy Clinical Research Network, Bressler NM, Miller KM, Beck RW, et al. Observational study of subclinical diabetic macular edema. Eye (Lond). 2012;26:833–840. doi:https://doi.org/10.1038/eye.2012.53.
- Waheed NK, Duker JS. OCT in the management of diabetic macular edema. Curr Ophthalmol. 2013;1:128–133. doi:https://doi.org/10.1007/s40135-013-0019-z.
- Gella L, Raman R, Sharma T. Macular thickness measurements using copernicus spectral domain optical coherence tomography. Saudi J Ophthalmol. 2015;29:121–125. doi:https://doi.org/10.1016/j.sjopt.2014.10.003.
- Diabetic Retinopathy Clinical Research Network; Writing Committee, Aiello LP, Beck RW, Bressler NM, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118:e5–e14. doi:https://doi.org/10.1016/j.ophtha.2011.09.058.
- Ranil PK, Raman R, Rachepalli SR, et al. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India. 2010;58:91–94.
- Raman R, Rani PK, Kulothungan V, et al. Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Ophthalmology. 2010;117(4):766–772. doi:https://doi.org/10.1016/j.ophtha.2009.09.005.
- Rani PK, Raman R, Gupta A, et al. Albuminuria and diabetic retinopathy in type 2 diabetes mellitus sankara nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, report 12). Diabetol Metab Syndr. 2011;3(1):9. doi:https://doi.org/10.1186/1758-5996-3-9.
- Raman R, Gupta A, Pal SS, et al. Prevalence of metabolic syndrome and its influence on microvascular complications in the Indian population with type 2 diabetes mellitus. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, report 14). Diabetol Metab Syndr. 2010;2:67. doi:https://doi.org/10.1186/1758-5996-2-67.
- Anusuya G, Gopalakrishnan S, Ravi R, et al. Prevalence of type 2 diabetes mellitus among people attending medical camps in South Chennai, India. Public health Rev: Int J Public health Res. 2015;2:32–37.
- Census of India Website. https://www.censusindia.gov.in/2011census/c-series/c-13.html. Accessed November 29, 2020.
- Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–564. doi:https://doi.org/10.2337/dc11-1909.
- Wang YT, Tadarati M, Wolfson Y, et al. Comparison of prevalence of diabetic macular edema based on monocular fundus photography vs optical coherence tomography. JAMA Ophthalmol. 2016;134:222–228. doi:https://doi.org/10.1001/jamaophthalmol.2015.5332.
- Deepa M, Pradeepa R, Rema M, et al. The Chennai urban rural epidemiology study (CURES): study design and methodology (urban component) (CURES-I). J Assoc Physicians India. 2003;51:863–870.
- Varma R, Bressler NM, Doan QV, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132:1334–1340. doi:https://doi.org/10.1001/jamaophthalmol.2014.2854.
- Keenan TD, Johnston RL, Donachie PH, et al. United Kingdom National Ophthalmology Database Study: diabetic Retinopathy; Report 1: prevalence of center-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services. Eye (Lond). 2013;27:1397–1404. doi:https://doi.org/10.1038/eye.2013.196.
- Aroca PR, Salvat M, Fernandez J, Mendez I. Risk factors for diffuse and focal macular edema. J Diabetes Complications. 2004;18:211–215. doi:https://doi.org/10.1016/S1056-8727(03)00038-2.
- Sugimoto M, Cutler A, Shen B, et al. Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage. Am J Pathol. 2013;183:987–995. doi:https://doi.org/10.1016/j.ajpath.2013.05.017.
- Zander E, Herfurth S, Bohl B, et al. Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol. 2000;84:871–876. doi:https://doi.org/10.1136/bjo.84.8.871.
- Kamoi K, Takeda K, Hashimoto K, et al. Identifying risk factors for clinically significant diabetic macula edema in patients with type 2 diabetes mellitus. Curr Diabetes Rev. 2013;9:209–217. doi:https://doi.org/10.2174/1573399811309030002.
- Benarous R, Sasongko MB, Qureshi S, et al. Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. Invest Ophthalmol Vis Sci. 2011;52:7464–7469. doi:https://doi.org/10.1167/iovs.11-7598.
- All India Ophthalmological Society. Home page http://www.aios.org/aboutaios. Accessed November 29, 2020.